Viewing Study NCT00499369


Ignite Creation Date: 2025-12-24 @ 10:47 PM
Ignite Modification Date: 2026-01-01 @ 10:19 AM
Study NCT ID: NCT00499369
Status: TERMINATED
Last Update Posted: 2014-07-31
First Post: 2007-07-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-06
Start Date Type: None
Primary Completion Date: 2012-11
Primary Completion Date Type: ACTUAL
Completion Date: 2012-11
Completion Date Type: ACTUAL
First Submit Date: 2007-07-10
First Submit QC Date: None
Study First Post Date: 2007-07-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2013-10-22
Results First Submit QC Date: None
Results First Post Date: 2014-01-15
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-07-25
Last Update Post Date: 2014-07-31
Last Update Post Date Type: ESTIMATED